Authors: Small, RE Wixted, MA Roberts, WN

Citation: Re. Small et al., Anakinra - An interleukin-1 receptor antagonist for treatment of rheumatoid arthritis, FORMULARY, 36(3), 2001, pp. 191

Authors: Rivest, C Lew, RA Welsing, PMJ Sangha, O Wright, EA Roberts, WN Liang, MH Karlson, EW

Citation: C. Rivest et al., Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus, J RHEUMATOL, 27(3), 2000, pp. 680-684

Authors: Liang, MH Corzillius, M Bae, SC Lew, RA Fortin, PR Gordon, C Isenberg, D Alarcon, GS Straaton, KV Denburg, S Esdaile, JM Glanz, BI Karlson, EW Khoshbin, S Rogers, MP Schur, PH Hanly, JG Kozora, E West, S Lahita, RG Lockshin, MD McCune, J Moore, PM Petri, M Roberts, WN Sanchez-Guerrero, J Veilleux, M Brey, R Cornblath, WD Filley, CM Fisk, JD Harten, P Hay, EM Iverson, G Levine, SR Waterhouse, E Wallace, DJ Winer, JB

Citation: Mh. Liang et al., The American College of Rheumatology Nomenclature and Case Definitions forNeuropsychiatric Lupus Syndromes, ARTH RHEUM, 42(4), 1999, pp. 599-608

Authors: Furst, DE Lindsley, H Baethge, B Botstein, GR Caldwell, J Dietz, F Ettlinger, R Golden, HE McLaughlin, GE Moreland, LW Roberts, WN Rooney, TW Rothschild, B Sack, M Sebba, AI Weisman, M Welch, KE Yocum, D

Citation: De. Furst et al., Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis - A randomized, double-blind six-week trial with eighteen-week extension, ARTH RHEUM, 42(2), 1999, pp. 357-365